PharmaJet announces Quadrivalent Influenza Vaccine for Needle-free delivery begins shipping for 2017-18 flu season

GOLDEN, Colo. – Aug. 29, 2017 – PharmaJet^® Inc., the maker of needle-free injection technology, today announced that shipping has begun for the quadrivalent influenza vaccine for needle-free delivery with the PharmaJet Stratis^® device for the 2017-18 influenza season.

“Adding a quadrivalent influenza vaccine to the already available trivalent vaccine offering with our Needle-free delivery means healthcare providers and patients now have a choice of vaccines for the upcoming flu season,” said Ron Lowy, PharmaJet Chairman and CEO. “Not only does Needle-free offer an alternative for those 25% of adults that fear needles⁽¹⁾, but it also gives pharmacies and flu clinic providers a way to differentiate their flu immunization program, and a way to drive increased immunization rates and store traffic.”

PharmaJet offers the only Needle-free delivery system cleared by the FDA for administration of inactivated influenza vaccines.

Refer to Instructions for Use to ensure safe injections and to review risks.
⁽¹⁾ Survey of the prevalence of immunization non-compliance due to needle fears in children and adults.” Taddio A, Ipp M, Thivakaran S, et al. Vaccine 2012; 30;4807-4812 Web. https://dx.doi.org/10.1016/j.vaccine.2012.05.011